Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

LITAK 2mg/ml solution for injection

Active Ingredient:
cladribine
Company:  
LIPOMED GmbH See contact details
ATC code: 
L01BB04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

DHPC for Cladribine (Litak and Leustat), 01 Dec 2017

{healthcare_pro_orange} For Healthcare Professionals
Risk of progressive multifocal leukoencephalopathy (PML)

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

LIPOMED GmbH
Company image
Address
Hegenheimer strasse 2, D - 79576 Weil/Rhein, Germany
Telephone
+49 7621 1693 473
Fax
+49 7621 1693474
E-mail
[email protected]
Medical Information Direct Line
+41 61 702 02 00
Medical Information Fax
+41 61 702 02 20
Medical Information e-mail
[email protected]
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0) 7395 177229
WWW
http://www.lipomed.com